Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Estimize announces data licensing agreement with Bloomberg

Thursday, April 18, 2013

Bailey McCann, Opalesque New York: Estimize, the buy side and independent analyst earnings estimates platform, today announced a licensing agreement with Bloomberg to feature Estimize’s earnings data on more than 900 publicly traded stocks via the Bloomberg Professional service’s news and research feeds. Opalesque recently interviewed Estimize CEO, Leigh Drogen about the company which seeks to open up earnings estimates and provide analysis not driven by sell-side incentives.

Estimize claims that its estimates are 67% more accurate than their sell-side cohorts. The company said in a statement today that the agreement with Bloomberg further validates this claim. The accuracy is driven by the diverse range of analysts contributing on Estimize, comprised of hedge fund, institutional buy-side, independent research and individual investors. Drogen, himself, was a former hedge fund quantitative analyst, and wants to improve upon the inherently conflicted estimates produced by the sell-side.

"The Bloomberg community consists of more than 300,000 financial professionals and we’re thrilled to be a part of that community as a data provider. In addition to validating the philosophy behind our process and accuracy of our earnings data, we believe the licensing agreement with Bloomberg will help drive an amazing set of new contributors to our platform, furth......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und